Skip to content

Analgesic effect of intravenous "magnesium sulfate" during bimaxillary orthognatic surgery

A Clinical Trial of Intravenous Infusion of "Magnesium Sulfate" During Orthognathic Surgery on Postoperative Pain.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201307101674N7
Enrollment
50
Registered
2013-07-29
Start date
2013-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bimaxillary Orthognathic Surgery. 00

Interventions

Intervention 1: Patients in the first group will be received Magnesium Sulfate an initial dose of 30 mg / kg body weight intravenously during 15 minutes and then continuously magnesium sulfate 10 mg /
Treatment - Drugs
Patients in the first group will be received Magnesium Sulfate an initial dose of 30 mg / kg body weight intravenously during 15 minutes and then continuously magnesium sulfate 10 mg / kg / hr via pum
The placebo group ( Normal saline) will be given an initial dose of the same volume of nomal saline intravenously and infusion of normal saline continued until end of surgery

Sponsors

Vice-Chancellery of Research and Technology, Shiraz University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients with no history of systemic disease and without taking any analgesic medications criteria that were willing to cooperate in this study were enrolled; and Exclusion criteria included known allergy to the study drugs; hepatic and renal dysfunction ; patients with heart block or myocardial damage; morbid obesity (BMI = 35); neuromuscular disease; history of neuropathy; asthma; Use of opioid or analgesics 3 days before the study; use of calcium channel blockers and Patients who did not sign the informed consent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The intensity of the pain. Timepoint: Every half hour for twelve hours after operation. Method of measurement: Visual analog scale.;Heart rate and blood pressure. Timepoint: Before, during and after surgery. Method of measurement: ECG and blood pressure monitoring device.;Duration of surgery. Timepoint: End of surgery. Method of measurement: The Minutes.

Secondary

MeasureTime frame
The use of sedative or narcotic. Timepoint: In the recovery room and surgical ward. Method of measurement: Visual analog scale.;Magnesium Sulfate side effects. Timepoint: Postoperative and in the ward Surgery. Method of measurement: Questionnaire.;Urine volume. Timepoint: From beginning to end the operation. Method of measurement: cc/kg/min.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Asghar Hosseini

Shiraz University Of Medical Sciences

hoseiniaa@sums.ac.ir+98 71 1624 0105

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026